Free Trial

Exelixis (EXEL) 10K Form and Latest SEC Filings 2026

Exelixis logo
$49.71 +1.55 (+3.22%)
Closing price 04:00 PM Eastern
Extended Trading
$49.68 -0.03 (-0.06%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Exelixis SEC Filings & Recent Activity

Exelixis (NASDAQ:EXEL) has submitted 815+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Exelixis's financial statements. The most recent filing was a Form 4 submitted on May 8, 2026.

Form 4
EXELIXIS, INC. Reports Ownership Change on May. 8, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-K
Exelixis Files Annual Report on Feb. 10, 2026

The 10-K contains Exelixis's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Exelixis SEC Filing History

Browse Exelixis' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/08/2026 6:03 PM
Exelixis (939767) Issuer
MORRISSEY MICHAEL (1202096) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 6:03 PM
Exelixis (939767) Issuer
POSTE GEORGE (1180770) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 6:03 PM
Exelixis (939767) Issuer
Freire Maria C (1547999) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 6:03 PM
Beckerle Mary C (1520181) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2026 3:36 PM
Exelixis (939767) Subject
POSTE GEORGE (1180770) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2026 5:49 PM
Exelixis (939767) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/17/2026 3:14 PM
Exelixis (939767) Filer
Form DEFA14A
04/15/2026 3:17 PM
Exelixis (939767) Filer
Form DEF 14A
04/15/2026 3:20 PM
Exelixis (939767) Filer
Form DEFA14A
03/26/2026 5:23 PM
Exelixis (939767) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/02/2026 6:59 PM
Exelixis (939767) Issuer
MORRISSEY MICHAEL (1202096) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 6:59 PM
Exelixis (939767) Issuer
Haley Patrick J. (1692954) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 6:59 PM
Exelixis (939767) Issuer
Hefti Brenda (2097579) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 6:59 PM
Exelixis (939767) Issuer
Senner Christopher J. (1648367) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 6:59 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 5:41 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 5:50 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2026 7:36 PM
Exelixis (939767) Issuer
WYSZOMIERSKI JACK L (1023225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2026 6:18 PM
Exelixis (939767) Issuer
Smith Julie (1557928) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 7:48 PM
Exelixis (939767) Issuer
Hefti Brenda (2097579) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 7:48 PM
Exelixis (939767) Issuer
Oliver Bob (1694534) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 7:49 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 7:49 PM
Eckhardt Sue Gail (1823769) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 7:49 PM
Exelixis (939767) Issuer
MORRISSEY MICHAEL (1202096) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 7:49 PM
Exelixis (939767) Issuer
Haley Patrick J. (1692954) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 7:49 PM
Exelixis (939767) Issuer
Senner Christopher J. (1648367) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 4:55 PM
Exelixis (939767) Subject
Smith Julie (1557928) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 5:45 PM
Exelixis (939767) Subject
Senner Christopher J. (1648367) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 5:47 PM
Exelixis (939767) Subject
Smith Julie (1557928) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 5:43 PM
Exelixis (939767) Subject
Haley Patrick J. (1692954) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2026 3:39 PM
Eckhardt Sue Gail (1823769) Reporting
Exelixis (939767) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2026 10:37 AM
AQR CAPITAL MANAGEMENT LLC (1167557) Filed by
Exelixis (939767) Subject
Form SCHEDULE 13G
02/12/2026 6:02 PM
Exelixis (939767) Subject
MORRISSEY MICHAEL (1202096) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2026 3:32 PM
Exelixis (939767) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/10/2026 3:08 PM
Exelixis (939767) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2026 6:02 PM
Exelixis (939767) Issuer
Senner Christopher J. (1648367) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 6:02 PM
Exelixis (939767) Issuer
Haley Patrick J. (1692954) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 6:02 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 6:03 PM
Exelixis (939767) Issuer
MORRISSEY MICHAEL (1202096) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 3:22 PM
Exelixis (939767) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2026 5:05 PM
Exelixis (939767) Subject
Farallon Capital Partners, L.P. (1175707) Filed by
Form SCHEDULE 13D/A
12/12/2025 5:08 PM
Exelixis (939767) Subject
Haley Patrick J. (1692954) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2025 5:51 PM
Exelixis (939767) Issuer
Hefti Brenda (2097579) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 6:47 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 6:47 PM
Exelixis (939767) Issuer
Haley Patrick J. (1692954) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 6:51 PM
Exelixis (939767) Issuer
Hefti Brenda (2097579) Reporting
Form 3
Initial statement of beneficial ownership of securities  
11/20/2025 3:02 PM
Exelixis (939767) Subject
Haley Patrick J. (1692954) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 7:11 PM
Exelixis (939767) Issuer
Oliver Bob (1694534) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 6:12 PM
Beckerle Mary C (1520181) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 6:12 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 6:12 PM
Exelixis (939767) Issuer
MORRISSEY MICHAEL (1202096) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 6:12 PM
Exelixis (939767) Issuer
PAPADOPOULOS STELIOS (1202098) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 4:41 PM
Exelixis (939767) Subject
PAPADOPOULOS STELIOS (1202098) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 9:30 AM
Aftab Dana (1959132) Reporting
Exelixis (939767) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 8:10 AM
Beckerle Mary C (1520181) Reporting
Exelixis (939767) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2025 3:30 PM
Exelixis (939767) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2025 5:57 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025 4:10 PM
Exelixis (939767) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2025 3:31 PM
Exelixis (939767) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/04/2025 6:57 PM
Exelixis (939767) Issuer
WYSZOMIERSKI JACK L (1023225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025 6:57 PM
Eckhardt Sue Gail (1823769) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025 4:22 PM
Caligan Partners LP (1727492) Reporting
Exelixis (939767) Issuer
JOHNSON DAVID EDWARD (1785557) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:12 PM
Exelixis (939767) Issuer
Smith Julie (1557928) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:12 PM
Eckhardt Sue Gail (1823769) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:13 PM
Exelixis (939767) Issuer
PAPADOPOULOS STELIOS (1202098) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:13 PM
Exelixis (939767) Issuer
Freire Maria C (1547999) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:13 PM
Exelixis (939767) Issuer
WYSZOMIERSKI JACK L (1023225) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:14 PM
Exelixis (939767) Issuer
POSTE GEORGE (1180770) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:14 PM
Exelixis (939767) Issuer
Heyman Tomas J. (1814673) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:14 PM
Exelixis (939767) Issuer
Oliver Bob (1694534) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 6:15 PM
Beckerle Mary C (1520181) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 6:25 PM
Exelixis (939767) Issuer
Heyman Tomas J. (1814673) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 6:25 PM
Exelixis (939767) Issuer
Haley Patrick J. (1692954) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025 4:59 PM
Exelixis (939767) Subject
Farallon Capital Partners, L.P. (1175707) Filed by
Form SCHEDULE 13D/A
05/20/2025 4:23 PM
Exelixis (939767) Subject
Haley Patrick J. (1692954) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025 7:57 PM
Exelixis (939767) Issuer
Peterson Amy C. (1682735) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 7:57 PM
Exelixis (939767) Issuer
Haley Patrick J. (1692954) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 7:57 PM
Exelixis (939767) Issuer
Hessekiel Jeffrey (1599803) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 7:57 PM
Exelixis (939767) Issuer
MORRISSEY MICHAEL (1202096) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 7:57 PM
Exelixis (939767) Issuer
PAPADOPOULOS STELIOS (1202098) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 7:58 PM
Exelixis (939767) Issuer
Senner Christopher J. (1648367) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 7:58 PM
Aftab Dana (1959132) Reporting
Exelixis (939767) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 7:58 PM
Exelixis (939767) Issuer
POSTE GEORGE (1180770) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025 5:00 PM
Exelixis (939767) Subject
PAPADOPOULOS STELIOS (1202098) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Exelixis SEC Filings - Frequently Asked Questions

Exelixis (EXEL) has submitted 815+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Exelixis's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Exelixis's financial statements page.

The most recent filing was a Form 4 submitted on May 8, 2026. This was an insider ownership change filed by 4 - EXELIXIS, INC. (0000939767) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:EXEL) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners